Penserra Capital Management LLC Tg Therapeutics, Inc. Transaction History
Penserra Capital Management LLC
- $4.61 Billion
- Q3 2024
A detailed history of Penserra Capital Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Penserra Capital Management LLC holds 98,144 shares of TGTX stock, worth $3.38 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
98,144
Previous 24,933
293.63%
Holding current value
$3.38 Million
Previous $444,000
416.89%
% of portfolio
0.05%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
339Shares Held
88.5MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$392 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$313 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$123 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$110 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...